Back to Search
Start Over
Bruton's tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis.
- Source :
-
Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2020 Dec; Vol. 25 (4), pp. 377-381. Date of Electronic Publication: 2020 Sep 21. - Publication Year :
- 2020
- Subjects :
- Agammaglobulinaemia Tyrosine Kinase metabolism
Animals
Drug Design
Humans
Multiple Sclerosis enzymology
Multiple Sclerosis physiopathology
Protein Kinase Inhibitors pharmacology
Agammaglobulinaemia Tyrosine Kinase antagonists & inhibitors
Multiple Sclerosis drug therapy
Protein Kinase Inhibitors therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1744-7623
- Volume :
- 25
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Expert opinion on emerging drugs
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32910702
- Full Text :
- https://doi.org/10.1080/14728214.2020.1822817